These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3214094)

  • 1. Liposomes as carriers of antifungal drugs.
    Lopez-Berestein G
    Ann N Y Acad Sci; 1988; 544():590-7. PubMed ID: 3214094
    [No Abstract]   [Full Text] [Related]  

  • 2. AmBisome today: expanding the perspectives on liposomal amphotericin B.
    Richardson M
    Acta Biomed; 2006; 77 Suppl 2():3-4. PubMed ID: 16918058
    [No Abstract]   [Full Text] [Related]  

  • 3. Liposomal amphotericin B for fever and neutropenia.
    Wingard JR
    N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515753
    [No Abstract]   [Full Text] [Related]  

  • 4. A perspective on liposomal amphotericin B (AmBisome).
    Richardson M; de Pauw B
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():1-4. PubMed ID: 18430125
    [No Abstract]   [Full Text] [Related]  

  • 5. Focus on fungal infections.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP
    Am J Med; 1986 May; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract]   [Full Text] [Related]  

  • 7. Liposomal formulations of amphotericin B: differences according to the scientific evidence.
    Azanza JR; Sádada B; Reis J
    Rev Esp Quimioter; 2015 Dec; 28(6):275-81. PubMed ID: 26621170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Update on therapy of invasive mycoses in hematology and oncology].
    Maschmeyer G; Haas A; Böhme A
    Dtsch Med Wochenschr; 2005 Jun; 130(22):1381-4. PubMed ID: 15915381
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of invasive Candida infection in neonates with congenital cutaneous Candidiasis.
    Melville C; Kempley ST
    Pediatrics; 2001 Jul; 108(1):216. PubMed ID: 11452964
    [No Abstract]   [Full Text] [Related]  

  • 10. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B.
    Eljaschewitsch J; Sandfort J; Tintelnot K; Horbach I; Ruf B
    Mycoses; 1996; 39(3-4):115-9. PubMed ID: 8767004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal amphotericin B for fever and neutropenia.
    Fischer T; Heussel G; Huber C
    N Engl J Med; 1999 Oct; 341(15):1152; author reply 1154-5. PubMed ID: 10515750
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposomal amphotericin B for fever and neutropenia.
    Prentice HG; Kibbler CC
    N Engl J Med; 1999 Oct; 341(15):1152-3; author reply 1154-5. PubMed ID: 10515751
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical study of amphotericin B in the treatment of invasive fungal infection in 111 hematological disorder patients with neutrocytopenia].
    Tong HY; Zhang FJ; Xiao F; Qian WB; Meng HT; Mai WY; Tong Y; Mao LP; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):472-5. PubMed ID: 19035181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal amphotericin B found safe and effective.
    AIDS Patient Care STDS; 1998 Jan; 12(1):69. PubMed ID: 11361899
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy with amphotericin B and other new antifungal agents.
    Riley HD
    J Okla State Med Assoc; 1974 Apr; 67(4):141-5. PubMed ID: 4596788
    [No Abstract]   [Full Text] [Related]  

  • 16. [Amphotericin B. Lipid complex versus liposomes. Which, why, when?].
    Pahissa A
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):1-3. PubMed ID: 9147499
    [No Abstract]   [Full Text] [Related]  

  • 17. Something new in coping with invasive fungal infections?
    Nardini S
    Monaldi Arch Chest Dis; 1995 Oct; 50(5):405-6. PubMed ID: 8541828
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipid derivatives of amphotericin B in treatment of systemic candidiasis].
    Rosenthal E
    Presse Med; 2000 Mar; 29(8):428. PubMed ID: 10738509
    [No Abstract]   [Full Text] [Related]  

  • 19. Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?
    Voltan AR; Quindós G; Alarcón KP; Fusco-Almeida AM; Mendes-Giannini MJ; Chorilli M
    Int J Nanomedicine; 2016; 11():3715-30. PubMed ID: 27540288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.